| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On October 12, 2005
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1979N-0043
|
| Lakes of Color Additives
|
|
|
|
|
| 1985N-0241
|
| Hematology & Pathology DEV/PMA/Automoted Blood Cell Seper
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| 2004P-0263
|
| To declare that the drug Cefixine chewable tablets, 100 mg, 150 mg, and 200 mg are suitable for an abbreviated new drug application ( ANDA)
|
|
|
|
|
| 2004P-0409
|
| metoclopramide hydrochloride orally disintegrating tablets 5 mg & 10 mg suitable for ANDA
|
|
|
|
|
| 2004Q-0151
|
| Qualified Health Claim (QHC): soy protein and cancer
|
|
|
|
|
| 2004Q-0201
|
| Qualified Health Claim (QHC): Lycopene, Tomatoes and Various Cancers
|
|
|
|
|
| 2005D-0195
|
| Guidance for Industry and FDA Staff; The Mammography Quality Standards Act Final Regulations: Modifications and Additions to Policy Guidance Help System #9
|
|
|
|
|
| 2005D-0288
|
| International Conference on Harmonisation; Draft Guidance on Q9 Quality Risk Management
|
|
|
|
|
| 2005N-0345
|
| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
|
|
|
|
|
| 2005N-0354
|
| Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
|
|
|
|
|
| 2005N-0393
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Investigational New Drug Regulations
|
|
|
|
|
| 2005P-0121
|
| Non-invasive Bone Growth Stimulator be reclassified from Class III to Class II
|
|
|
|
|
| 2005P-0409
|
| Refuse Approval of NDA for Olopatadine Hydrochloride Nasal Spray
|
|
|
|
|
| 2005V-0314
|
| Laser Light Show
|
|
|
|
|
| 1979N-0043
|
| Lakes of Color Additives
|
|
|
|
|
| REF 1
|
| No Submitter
|
| Vol #:
|
| 3
|
|
|
|
|
| 1985N-0241
|
| Hematology & Pathology DEV/PMA/Automoted Blood Cell Seper
|
|
|
|
|
| REF 1
|
| No Submitter
|
| Vol #:
|
| 5
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| C 7506
|
| W Whitehurst and 41 signatures
|
| Vol #:
|
| 319
|
|
|
|
|
| 2004P-0263
|
| To declare that the drug Cefixine chewable tablets, 100 mg, 150 mg, and 200 mg are suitable for an abbreviated new drug application ( ANDA)
|
|
|
|
|
| PAV
1
|
| HFD-600 to Lupin Pharmaceuticals Inc
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0409
|
| metoclopramide hydrochloride orally disintegrating tablets 5 mg & 10 mg suitable for ANDA
|
|
|
|
|
| WDL
1
|
| Lachman Consultant Services Inc
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004Q-0151
|
| Qualified Health Claim (QHC): soy protein and cancer
|
|
|
|
|
| LET
10
|
| HFS-800 to Solae LLC
|
| Vol #:
|
| 9
|
|
| |
|
| 2004Q-0201
|
| Qualified Health Claim (QHC): Lycopene, Tomatoes and Various Cancers
|
|
|
|
|
| LET
10
|
| H J Heinz Company
|
| Vol #:
|
| 16
|
|
|
|
|
| 2005D-0195
|
| Guidance for Industry and FDA Staff; The Mammography Quality Standards Act Final Regulations: Modifications and Additions to Policy Guidance Help System #9
|
|
|
|
|
| C
1
|
| American College of Radiology
|
| Vol #:
|
| 1
|
|
